Clinical trials: A need to better define the control group as current standard of care

Ophthalmology

Volumn 122, Issue 3, 2015, Pages 443-444

  Bakri, Sophie J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; NEW DRUG; RANIBIZUMAB; HYBRID PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VEGFA PROTEIN, HUMAN;

AGE RELATED MACULAR DEGENERATION; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CLINICAL TRIAL (TOPIC); EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH CARE QUALITY; HUMAN; LOW LEVEL LASER THERAPY; MACULAR EDEMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGISTRATION; RETINA CAPILLARY; RETINA HEMORRHAGE; RETINA VEIN OCCLUSION; STANDARDIZATION; TREATMENT OUTCOME; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; FEMALE; MALE; RETINAL VEIN OCCLUSION;

FEMALE; HUMANS; MACULAR EDEMA; MALE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RETINAL VEIN OCCLUSION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84924040903     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.01.010     Document Type: Editorial

References (7)

1. P.A. Campochiaro, J.S. Heier, and L. Feiner Ranibizumab for macular edema following branch retinal vein occlusion: 6-month primary endpoint results of a phase III study Ophthalmology 117 2010 1102 1112
2. P.A. Campochiaro, W.L. Clark, and D.S. Boyer Intravitreal aflibercept for macular edema following branch retinal vein occlusion: The 24-week results of the VIBRANT study Ophthalmology 122 2015 538 544
3. The Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 1984 271 282
4. D.M. Brown, V. Chong, J.F. Korobelnik VIEW 1 and VIEW 2 Study Groups Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration Ophthalmology 119 2012 2537 2548
5. Macular Photocoagulation Study Group Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial Arch Ophthalmol 109 1991 1220 1231
6. Food and Drug Administration. Guidance for Industry: E 10 Choice of Control Group and Related Issues in Clinical Trials. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073139.pdf. Accessed January 5, 2014.
7. American Society of Retina Specialists. The Preferences and Trends Survey. Available at: http://www.asrs.org/content/documents/-patsurvey2011.pdf. Accessed January 5, 2014.